Следене
Matej Orešič
Matej Orešič
Professor of Medical Sciences (Systems Medicine), Örebro University & Turku Bioscience Centre
Потвърден имейл адрес: oru.se - Начална страница
Заглавие
Позовавания
Позовавания
Година
MZmine 2: modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data
T Pluskal, S Castillo, A Villar-Briones, M Orešič
BMC bioinformatics 11 (1), 1-11, 2010
32942010
Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist
SI Sayin, A Wahlström, J Felin, S Jäntti, HU Marschall, K Bamberg, ...
Cell metabolism 17 (2), 225-235, 2013
18582013
Human gut microbes impact host serum metabolome and insulin sensitivity
HK Pedersen, V Gudmundsdottir, HB Nielsen, T Hyotylainen, T Nielsen, ...
Nature 535 (7612), 376-381, 2016
14842016
The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes
AD Kostic, D Gevers, H Siljander, T Vatanen, T Hyötyläinen, ...
Cell host & microbe 17 (2), 260-273, 2015
10592015
MZmine: toolbox for processing and visualization of mass spectrometry based molecular profile data
M Katajamaa, J Miettinen, M Orešič
Bioinformatics 22 (5), 634-636, 2006
8842006
Data processing for mass spectrometry-based metabolomics
M Katajamaa, M Orešič
Journal of chromatography A 1158 (1-2), 318-328, 2007
7472007
Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance
M López, L Varela, MJ Vázquez, S Rodríguez-Cuenca, CR González, ...
Nature medicine 16 (9), 1001-1008, 2010
7292010
Mitofusin 2 (Mfn2) links mitochondrial and endoplasmic reticulum function with insulin signaling and is essential for normal glucose homeostasis
D Sebastián, MI Hernández-Alvarez, J Segalés, E Sorianello, JP Muñoz, ...
Proceedings of the National Academy of Sciences 109 (14), 5523-5528, 2012
6262012
The gut microbiota modulates host energy and lipid metabolism in mice [S]
VR Velagapudi, R Hezaveh, CS Reigstad, P Gopalacharyulu, L Yetukuri, ...
Journal of lipid research 51 (5), 1101-1112, 2010
6222010
Processing methods for differential analysis of LC/MS profile data
M Katajamaa, M Orešič
BMC bioinformatics 6 (1), 1-12, 2005
5222005
Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer ProgressionLipidomic Changes in Breast Cancer Progression
M Hilvo, C Denkert, L Lehtinen, B Müller, S Brockmöller, ...
Cancer research 71 (9), 3236-3245, 2011
5152011
Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes
M Oresic, S Simell, M Sysi-Aho, K Nanto-Salonen, T Seppanen-Laakso, ...
The Journal of experimental medicine 205 (13), 2975-2984, 2008
4832008
Metabolomics enables precision medicine:“a white paper, community perspective”
RD Beger, W Dunn, MA Schmidt, SS Gross, JA Kirwan, M Cascante, ...
Metabolomics 12, 1-15, 2016
4672016
PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism
G Medina-Gomez, SL Gray, L Yetukuri, K Shimomura, S Virtue, ...
PLoS genetics 3 (4), e64, 2007
4652007
Integration of microRNA miR-122 in hepatic circadian gene expression
D Gatfield, G Le Martelot, CE Vejnar, D Gerlach, O Schaad, F Fleury-Olela, ...
Genes & development 23 (11), 1313-1326, 2009
4472009
Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects–a monozygotic twin study
KH Pietiläinen, M Sysi-Aho, A Rissanen, T Seppänen-Laakso, ...
PloS one 2 (2), e218, 2007
4452007
Gene-to-metabolite networks for terpenoid indole alkaloid biosynthesis in Catharanthus roseus cells
H Rischer, M Orešič, T Seppänen-Laakso, M Katajamaa, F Lammertyn, ...
Proceedings of the National Academy of Sciences 103 (14), 5614-5619, 2006
3902006
Differential lipid partitioning between adipocytes and tissue macrophages modulates macrophage lipotoxicity and M2/M1 polarization in obese mice
X Prieur, CYL Mok, VR Velagapudi, V Núñez, L Fuentes, D Montaner, ...
Diabetes 60 (3), 797-809, 2011
3852011
Pathways to the analysis of microarray data
RK Curtis, M Orešič, A Vidal-Puig
TRENDS in Biotechnology 23 (8), 429-435, 2005
3852005
Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease
PK Luukkonen, Y Zhou, S Sädevirta, M Leivonen, J Arola, M Orešič, ...
Journal of hepatology 64 (5), 1167-1175, 2016
3792016
Системата не може да изпълни операцията сега. Опитайте отново по-късно.
Статии 1–20